Target intelligence / Profile preview

Stromal cell-derived factor 2-like protein 1 (SDF2L1)

Target
SDF2L1
Molecular classification
Other (Endoplasmic reticulum-resident chaperone-related protein)
01

Overview

Stromal cell-derived factor 2-like protein 1 (SDF2L1) is an endoplasmic reticulum (ER)-resident protein involved in protein folding, serving as a chaperone cofactor that binds misfolded proteins and participates in the cellular response to ER stress[1][3][5]. It is ubiquitously expressed across human tissues, with higher levels found in the testis and moderate to low expression in other organs[4]. SDF2L1 expression is upregulated during ER stress and the unfolded protein response, contributing to cellular homeostasis and stress adaptation. In cancer, lower SDF2L1 expression has been associated with poor patient prognosis, particularly in breast and ovarian cancer, suggesting its utility as a prognostic biomarker. However, its precise biological role, especially regarding therapeutic targeting, remains incompletely understood and is currently not considered a direct therapeutic target[1][3][4][6].

Other names
Stromal cell-derived factor 2-like protein 1SDF2L1SDF2-like protein 1PWP1-interacting protein 8Dihydropyrimidinase-like 2AP000553.C22.4OTTHUMT00000075032SDF2LLOC683036
02

Biological functions

Protein foldingChaperone cofactor-dependent protein refoldingMisfolded protein bindingCellular stress response (ER stress/Unfolded Protein Response)
03

Disease associations

Cancer (biomarker/prognostic association in breast and ovarian cancer)Corneal dystrophy, subepithelial mucinousSevere congenital neutropenia 7
04

Biomarkers

Prognostic biomarker in breast cancer (low expression associated with poor prognosis)Prognostic biomarker in ovarian serous carcinoma (low expression associated with poor prognosis)

Beyond the preview

Go deeper on Stromal cell-derived factor 2-like protein 1 (SDF2L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stromal cell-derived factor 2-like protein 1 (SDF2L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call